Neuropace Inc at JPMorgan Healthcare Conference Transcript
Great. Hey, everyone. Good morning. I'm Lily Lozada, I'm on the medtech research team here at JPMorgan. And I'm happy to have the NeuroPace management team with us here today.
I'll pass it over to CEO, Joel Becker, for a presentation, and then we'll do some Q&A.
Good morning. Thank you, Lily. Thank you to JP Morgan as well for having us. And thanks to all of you for being with us here, bright and early on a Thursday morning, and to everybody joining.
My name is Joel Becker. I'm the President and CEO of NeuroPace. And I'm excited to be here with our leadership team, members of our leadership team, to tell you about who we are and what we do, our current status, and why we're excited about where we're headed. So with that, I'll get right to it.
Please note our disclaimers. And I'll start with who NeuroPace is. It's best defined by our mission. You can see it here. And that is to transform the lives of people suffering
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
